Is it time to revise linezolid dose in elderly patients?-Reference-Cited by-同舟云学术

Is it time to revise linezolid dose in elderly patients?

Published:2017-07-15 Issue:10 Volume:73 Page:1335-1336
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Tinelli Marco,Gervasoni Cristina,Piazza Manuela,Terzi Roberta,Cozzi Valeria,Maffezzini Elena,Cerri Chiara,Castoldi Simone,Baldelli Sara,Cattaneo Dario

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-017-2303-6/fulltext.html

Reference10 articles.

1. Abe S, Chiba K, Cirincione B et al (2009) Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients. J Clin Pharmacol 49:1071–1078

2. Cattaneo D, Gervasoni C, Cozzi V et al (2016) Therapeutic drug management of linezolid: a missed opportunity for clinicians? Int J Antimicrob Agents 48:728–731

3. Cattaneo D, Alffenaar JW, Neely M (2016) Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. Expert Opin Drug Metab Toxicol 12:533–544

4. Pea F, Furlanut M, Cojutti P et al (2010) Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob Agents Chemother 54:4605–4610

5. Cattaneo D, Orlando G, Cozzi V et al (2013) Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections. Int J Antimicrob Agents 41:586–589

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study;Journal of Antimicrobial Chemotherapy;2024-06-14

2. Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological Toxicities;Infection and Drug Resistance;2024-06

3. Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients;European Journal of Clinical Pharmacology;2024-05-27

4. Linezolid dose adjustment according to therapeutic drug monitoring helps reach the goal concentration in severe patients, and the oldest seniors benefit more;BMC Infectious Diseases;2023-11-29

5. Nomogram prediction model called “ADPLCP” for predicting linezolid-associated thrombocytopenia in elderly individuals;Journal of Intensive Medicine;2023-07